1. STAT3, a Master Regulator of Anti-Tumor Immune Response
   null Rébé et al, 2019, Cancers CrossRef
2. null
   Kris Vaddi, 2017 CrossRef
3. Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy
   Simran Venkatraman et al, 2020, Vaccines CrossRef
4. Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway
   Ruoyu Wang et al, 2021, BMC Infect Dis CrossRef
5. Role of CD8+ T lymphocyte cells: Interplay with stromal cells in tumor microenvironment
   Qin Xie et al, 2021, Acta Pharmaceutica Sinica B CrossRef
6. Adiponectin Deficiency Enhances Anti-Tumor Immunity of CD8+ T Cells in Rhabdomyosarcoma Through Inhibiting STAT3 Activation
   Jiao Peng et al, 2022, Front. Oncol. CrossRef
7. Gallic acid enhances anti-lymphoma function of anti-CD19 CAR-T cells in vitro and in vivo
   Zhiqiang Luo et al, 2023, Mol Biomed CrossRef
8. Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing
   Yushan Dong et al, 2023, Biomedicine & Pharmacotherapy CrossRef
9. Phosphoflow cytometry to assess cytokine signaling pathways in peripheral immune cells: potential for inferring immune cell function and treatment response in patients with solid tumors
   Nicole J. Toney et al, 2023, J Exp Clin Cancer Res CrossRef
10. Deregulated transcription factors in the emerging cancer hallmarks
    Adria Hasan et al, 2023, Seminars in Cancer Biology CrossRef
11. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
    Yamei Hu et al, 2024, J Exp Clin Cancer Res CrossRef